Literature DB >> 6349044

Peripheral blood T lymphocytes found in renal allograft recipients treated with cyclosporine.

M Liebert, J T Rosenthal, E Merrall, R J Taylor, G Singh, T E Starzl, B S Rabin, T R Hakala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6349044      PMCID： PMC2975400          DOI： 10.1097/00007890-198308000-00019

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  12 in total

1.  Immunological monitoring of renal allograft recipients using monoclonal antibodies to human T lymphocyte subpopulations.

Authors:  T M Ellis; C R Berry; G Mendez-Picon; M H Goldman; R R Lower; H M Lee; T Mohanakumar
Journal:  Transplantation       Date:  1982-03       Impact factor: 4.939

Review 2.  Cyclosporin A.

Authors:  P J Morris
Journal:  Transplantation       Date:  1981-11       Impact factor: 4.939

3.  Cyclosporin A blocks receptors for HLA-DR antigens on T cells.

Authors:  R Palacios; G Möller
Journal:  Nature       Date:  1981-04-30       Impact factor: 49.962

4.  Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.

Authors:  R Y Calne; K Rolles; D J White; S Thiru; D B Evans; P McMaster; D C Dunn; G N Craddock; R G Henderson; S Aziz; P Lewis
Journal:  Lancet       Date:  1979-11-17       Impact factor: 79.321

5.  Nephrotoxicity of cyclosporin A in liver and kidney transplant patients.

Authors:  G B Klintmalm; S Iwatsuki; T E Starzl
Journal:  Lancet       Date:  1981-02-28       Impact factor: 79.321

6.  Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen.

Authors:  R L Evans; D W Wall; C D Platsoucas; F P Siegal; S M Fikrig; C M Testa; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

7.  Human T cell subpopulations defined by a monoclonal antibody. I. A small subset is responsible for proliferation to allogeneic cells or to soluble antigens and for helper activity for B cell differentiation.

Authors:  G Corte; M C Mingari; A Moretta; G Damiani; L Moretta; A Bargellesi
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

8.  Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.

Authors:  A B Cosimi; R B Colvin; R C Burton; R H Rubin; G Goldstein; P C Kung; W P Hansen; F L Delmonico; P S Russell
Journal:  N Engl J Med       Date:  1981-08-06       Impact factor: 91.245

9.  Cyclosporin A spares selectively lymphocytes with donor-specific suppressor characteristics.

Authors:  I F Hutchinson; C A Shadur; J S Duarte; T B Strom; N L Tilney
Journal:  Transplantation       Date:  1981-09       Impact factor: 4.939

10.  Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.

Authors:  D Bunjes; C Hardt; M Röllinghoff; H Wagner
Journal:  Eur J Immunol       Date:  1981-08       Impact factor: 5.532
View more
  2 in total

1.  Cell-mediated cytotoxicity in acute rat cardiac allograft rejection: an immunological and ultrastructural study.

Authors:  T Hayashi; M Nozawa; I Otsu; H Deguchi; Y Kitaura; K Kawamura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  [The effect of rejection crises and immunosuppressive therapy on the lymphocyte subpopulations of patients after kidney transplantation].

Authors:  A v Kiparski; D Frei; W Fierz; G Frei; G Uhlschmid; F Largiader; U Binswanger
Journal:  Klin Wochenschr       Date:  1990-04-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.